https://www.fredhutch.org/en/news/releases/rss2014-09-09T19:10:20.086ZNews Releases RSS FeedAdobe Experience ManagerFred Hutchinson Cancer Research Center designated MIDAS Center of ExcellenceResearchers at Fred Hutchinson Cancer Research Center received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence. Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism.https://www.fredhutch.org/en/news/releases/2014/09/fred-hutch-seattle-biomed-malaria-clinical-trials/fred-hutch-designated-midas-center-of-excellence2014-09-17T07:00:00.000Z2014-09-17T07:00:00.000ZFred Hutchinson Cancer Research Center and Seattle BioMed team up on malaria clinical trialsResearchers at Fred Hutchinson Cancer Research Center and the Seattle Vaccine Trials Unit (a program of Fred Hutch) have begun a collaboration with Seattle BioMed and its Malaria Clinical Trials Center (MCTC) for upcoming malaria clinical research studies of experimental drugs that may prevent and/or treat malaria, which include a malaria challenge. As part of these studies, malaria will be delivered to participants by the bites of five infected mosquitos.https://www.fredhutch.org/en/news/releases/2014/09/fred-hutch-seattle-biomed-malaria-clinical-trials2014-09-09T21:06:28.000Z2014-09-09T21:06:28.000ZActionable Genome Consortium forms with cross disciplinary leaders from world-renowned cancer institutions https://www.fredhutch.org/en/news/releases/2014/09/actionable-genome-consortium-world-renowned-cancer-institutions2014-09-08T16:25:35.000Z2014-09-08T16:25:35.000ZGene therapy boosts chemotherapy tolerance and effectiveness of medications that attack brain cancerUsing gene therapy and a cocktail of powerful chemotherapy drugs, researchers at Fred Hutchinson Cancer Research Center have been able to boost the tolerance and effectiveness of medications that attack brain cancer while also shielding healthy cells from their devastating effects. https://www.fredhutch.org/en/news/releases/2014/08/gene-therapy-boosts-chemotherapy-tolerance2014-08-08T20:50:47.000Z2014-08-08T20:50:47.000ZFred Hutch's Obliteride rolls across western Washington this weekendObliteride gains momentum in its second year as cancer survivors, cyclists, researchers and others determined to end cancer ride this weekend to raise money for Fred Hutchinson Cancer Research Center. In its inaugural year, Obliteride 2013 raised nearly $2 million for lifesaving cancer research at Fred Hutch. With the community’s help, organizers hope to collect even more in 2014. https://www.fredhutch.org/en/news/releases/2014/08/obliteride-rolls-across-western-washington-this-weekend2014-08-05T17:25:52.000Z2014-08-05T17:25:52.000ZFred Hutchinson Cancer Research Center researcher Veena Shankaran to receive ‘40 Under 40’ awardThe Puget Sound Business Journal has recognized Veena Shankaran, M.D., a medical oncologist and health economist at Fred Hutchinson Cancer Research Center, as one of 40 individuals under age 40 who have demonstrated extraordinary leadership within their field. Shankaran will accept the award, now in its 16th year, at a PSBJ reception honoring all 40 recipients later this fall.https://www.fredhutch.org/en/news/releases/2014/07/fred-hutch-researcher-veena-shankaran-40-under-40-award2014-07-25T21:42:08.000Z2014-07-25T21:42:08.000ZScience teachers dedicate summer vacation to improving science education Fred Hutchinson Cancer Research Center More than 20 science teachers from communities across Washington are spending part of their summer vacation at “school,” working beside scientists in research laboratories at Fred Hutchinson Cancer Research Center and partner sites throughout Seattle. https://www.fredhutch.org/en/news/releases/2014/07/Science-teachers-dedicate-summer-vacation-to-improving-science-education2014-07-11T07:00:00.000Z2014-07-11T07:00:00.000ZIntiman Theatre and Fred Hutch announce innovative partnership to raise awareness of HIV vaccine research during ‘Angels in America’The Tony Award-winning Intiman Theatre has partnered with world-renowned Fred Hutchinson Cancer Research Center to raise awareness of Fred Hutch’s HIV vaccine research. The collaboration is part of Intiman’s 2014 summer theatre festival, THE ANGELS PROJECT, inspired by “Angels in America,” Tony Kushner’s award-winning, two-play masterpiece about the devastating outbreak of HIV in 1980s New York City.https://www.fredhutch.org/en/news/releases/2014/07/intiman-fred-hutch-HIV-vaccine-partnership2014-07-08T22:32:00.000Z2014-07-08T22:32:00.000ZObliteride announces stellar music lineup for ride weekend Aug. 8-10https://www.fredhutch.org/en/news/releases/2014/06/obliteride-music-lineup-ride-weekend-aug-8-10-20142014-07-01T17:13:54.000Z2014-07-01T17:13:54.000ZFred Hutchinson Cancer Research Center celebrates Seattle PrideFest - Fred Hutchinson Cancer Research CenterNearly 100 Fred Hutchinson Cancer Research Center employees, family members and friends will join in Seattle’s PrideFest 2014 parade on Sunday, June 29. The team from Fred Hutch will be walking the 1.75-mile route in support of the diversity and ongoing accomplishments of the area’s LGBT community.https://www.fredhutch.org/en/news/releases/2014/06/fred-hutch-celebrates-seattle-pridefest2014-06-27T18:28:07.000Z2014-06-27T18:28:07.000ZBrewing yeasts reveal secrets of chromosomal warfare and dysfunction - Fred Hutchinson Cancer Research CenterUsing two yeasts that have been used to brew tea and beer for centuries, researchers at Fred Hutchinson Cancer Research Center have revealed how reproductive barriers might rapidly arise to create species boundaries. Schizosaccharomyces pombe has been used to brew beer in Africa, whereas its close relative S. kombucha is a component of kombucha tea commonly found in health-food stores.https://www.fredhutch.org/en/news/releases/2014/06/brewing-yeasts-reveal-secrets-of-chromosomal-warfare-and-dysfunction2014-06-24T21:44:03.000Z2014-06-24T21:44:03.000ZWashington Gov. Jay Inslee appoints Fred Hutchinson Cancer Research Center health economist Scott Ramsey to new Performance Measures Committeehttps://www.fredhutch.org/en/news/releases/2014/06/inslee-appoints-scott-ramsey-to-performance-committee2014-06-10T23:14:50.000Z2014-06-10T23:14:50.000ZValue in Cancer Care Initiative Town Hall welcomes input on oncology value measures - Fred Hutchinson Cancer Research CenterThe Value in Cancer Care Initiative, part of the Hutchinson Institute for Cancer Outcomes Research, will hold a public forum on Monday, May 19 from 3 to 5 p.m.
The public forum is an interactive and inclusive process that will provide an opportunity for attendees to discuss and refine the top six value metrics in oncology, which originated from the Value in Cancer Care Summit held in January.https://www.fredhutch.org/en/news/releases/2014/05/value-in-cancer-care-initiative-town-hall2014-05-16T18:32:39.000Z2014-05-16T18:32:39.000ZStudy projects doubling of the proportion diagnosed with early-stage lung cancer if Medicare implements recommended LDCT screening - Fred Hutchinson Cancer Research CenterRecommendations by the U.S. Preventive Services Task Force suggest annual low dose computed tomography (LDCT) screening for lung cancer in high-risk patients. A new study projects that implementing this screening policy in the Medicare program could result in approximately 54,900 more lung cancer cases detected over a five-year period, a majority of which would be early-stage disease. https://www.fredhutch.org/en/news/releases/2014/05/study-projects-doubling-of-proportion-diagnosed-with-early-stage-lung-cancer-if-ldct-screening2014-05-14T22:55:39.000Z2014-05-14T22:55:39.000Z Dr. Larry Corey to step down as President and Director of Fred Hutchinson Cancer Research Center - Fred Hutchinson Cancer Research CenterFred Hutchinson Cancer Research Center today announced that Dr. Larry Corey will step down as President and Director to return to his passion and focus on research. Corey will turn his attention from scientific administration back to his longstanding research focus to develop vaccines for HIV and herpes viruses.https://www.fredhutch.org/en/news/releases/2014/05/larry-corey-to-step-down-as-president-and-director-of-fred-hutch2014-05-08T16:28:50.000Z2014-05-08T16:28:50.000ZWomen’s Health Initiative reports $37.1B economic return on combined hormone therapy clinical trial - Fred Hutchinson Cancer Research CenterThe WHI is one of the largest National Institutes of Health-funded studies ever conducted on women. Housed at the Fred Hutchinson Cancer Research Center in Seattle, it is a 15-year, multimillion-dollar study established in 1991, involving more than 160,000 women nationwide, including some 3,500 in Washington.
The overall economic return from the WHI E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published, providing a return of approximately $140 on every dollar invested in the trial.
https://www.fredhutch.org/en/news/releases/2014/05/womens-health-initiative-reports-37-billion-economic-return2014-05-05T19:56:40.000Z2014-05-05T19:56:40.000ZA 30-year puzzle in breast cancer is solved - Fred Hutchinson Cancer Research CenterIn a new study published today in Cell Reports, scientists at the Fred Hutchinson Cancer Research Center demonstrate that mice lacking one copy of a gene called CTCF have abnormal DNA methylation and are markedly predisposed to cancer. CTCF is a very well-studied DNA binding protein that exerts a major influence on the architecture of the human genome, but had not been previously linked to cancer. https://www.fredhutch.org/en/news/releases/2014/04/30-year-puzzle-breast-cancer-solved2014-05-01T22:33:13.000Z2014-05-01T22:33:13.000Z2Morrow Announces Licensing Agreement with Fred Hutchinson Cancer Research Center - Fred Hutchinson Cancer Research Center2Morrow, Inc. announced today an exclusive licensing agreement with Fred Hutchinson Cancer Research Center to commercialize the first Smartphone-delivered, smoking cessation app that is scientifically proven to help smokers quit. https://www.fredhutch.org/en/news/releases/2014/04/2morrow-licensing-agreement-with-fred-hutch2014-04-29T18:25:11.000Z2014-04-29T18:25:11.000ZLight the Way for Cancer Research Month - Fred Hutchinson Cancer Research CenterOn the eve of National Cancer Research Month, people impacted by cancer will come together on the shores of Lake Union for a special lantern lighting ceremony honoring loved ones and supporting lifesaving cancer research at Seattle’s Fred Hutchinson Cancer Research Center. https://www.fredhutch.org/en/news/releases/2014/04/light-the-way-for-cancer-research-month2014-04-29T16:45:11.000Z2014-04-29T16:45:11.000ZVitamin D and its effect on weight loss examined in new study - Fred Hutchinson Cancer Research CenterA new study published online April 18 in the American Journal of Clinical Nutrition suggests that healthy or “replete” levels of vitamin D may be associated with weight loss in a certain segment of postmenopausal overweight women.https://www.fredhutch.org/en/news/releases/2014/04/vitamin-d-effect-on-weight-loss2014-04-22T17:23:33.000Z2014-04-22T17:23:33.000Z